Syndax Pharmaceuticals SNDX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Syndax Pharmaceuticals's investment purchases?
- Syndax Pharmaceuticals (SNDX) reported investment purchases of $39.39M in Q1 2026.
- How has Syndax Pharmaceuticals's investment purchases changed year-over-year?
- Syndax Pharmaceuticals's investment purchases increased by 273.8% year-over-year, from $10.54M to $39.39M.
- What is the long-term trend for Syndax Pharmaceuticals's investment purchases?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's investment purchases has grown at a -9.7% compound annual growth rate (CAGR), from $294.72M to $195.81M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.